The fat embolism syndrome (FES) is considered a clinical diagnosis. It typically occurs within several days following major traumatic injury, usually involving fractures of the pelvis and/or lower extremities. Fat embolism syndrome is characterized by the onset of respiratory, neurological, cutaneous, and hematologic manifestations and is thought to be related to intravascular embolization of fat, presumably arising from within the fractured bone marrow space. In its most severe form, FES can be lethal. The presence of fat emboli within the microvasculature of the lungs, brain, and sometimes other organs verifies the clinical impression of FES. Despite its relatively well-known clinical characterization, debate exists within the clinical literature regarding the most appropriate diagnostic criteria for FES. Given this fact, along with the fact that FES is a clinical diagnosis, it is not surprising that forensic pathologists may be somewhat reluctant to make a postmortem diagnosis of FES, especially in cases where insufficient clinical information is available. A case of fatal FES is presented in which rapid clinical deterioration occurred, followed by death, such that a clinical diagnosis of FES was never rendered. We propose that, given the correct circumstances, clinical scenario, and autopsy findings, it is appropriate and acceptable to make a postmortem diagnosis of FES. A multitiered approach to the postmortem diagnosis of FES is presented.
T he first clinical description of fat embolism syndrome (FES) was presented in 1862, by Zenker, who showed that fat was found in the pulmonary capillaries at autopsy of a severe crush victim. 1 Soon after, Von Bergmann diagnosed FES, in 1873, in a man with a fractured femur, and, in 1879, Fenger and Salisbury described the syndrome in the American literature. 2, 3 The phenomenon of fat emboli has fascinated and perplexed investigators ever since its first description.
There is a distinction between the terms ''fat embolism'' and ''fat embolism syndrome.'' 2, 4 The life-threatening syndrome, a clinical diagnosis based on certain clinical symptoms and signs, must be distinguished from fat embolization alone, a situation that is usually considered a harmless phenomenon. There is often overlap between the 2 definitions in the literature, which leads to some disparity in diagnosis. Fat emboli can arise in pulmonary and systemic circulation after fracture of long bones and rarely after extensive soft tissue trauma and burns. 2, 5 Fat emboli originate from bone marrow or adipose tissue and enter the circulation via ruptured vascular sinusoids or venules. 5 Fat embolism syndrome encompasses a spectrum of symptoms and signs of respiratory, neurological, cutaneous, and hematologic impairment. 5, 6 Several authors have proposed specific criteria, ranging from laboratory, clinical, or radiographic signs, for the diagnosis of FES. Most notable of these criteria are those of Gurd, 7 which will be discussed later. 1 Fat embolism syndrome symptoms typically occur within 12 to 72 hours following injury with the gradual onset of respiratory insufficiency, neurological symptoms, and petechial rash. 2, 6 Most patients will have clinical symptoms within 24 hours of injury; some may appear immediately, whereas others may present a week following injury. 2, 3, 8 The classic syndrome involves the lungs, brain, and skin, but other target organs can also be affected by fat emboli (eg, the retina and kidneys). Fat embolism syndrome is a diagnosis of exclusion because some of the manifestations are seen in other illnesses. 9 We report a case of a patient who had deteriorating neurological status, respiratory insufficiency, and death after suffering multiple fractures in an automobile accident. We attribute the patient's symptoms and postmortem findings to FES, even though the patient did not meet the classic criteria of FES. The varying criteria for definition of FES make both epidemiology of cause of death or morbidity difficult to ascertain. Fat embolism syndrome has several variations of presentation, and diagnosis is often elusive. We agree with Chan et al, 10 who state that the disparity in the incidence of fat embolism is due to the difference in the emphasis on the criteria for diagnosis. Some authors 5, 11 have recommended alterations and amendments to earlier criteria of Gurd and Schonfeld. We have not found an objective set of criteria that would especially be useful for a forensic pathologist to make a postmortem diagnosis of FES because diagnostic criteria are based on the clinical picture. We propose criteria to aid in the postmortem diagnosis of suspected FES, especially in cases such as ours, when death rapidly ensues from time of injury so as not to allow major clinical manifestations of FES to appear. Objective criteria based on clinical, radiographic, and autopsy findings would be most helpful in determining the cause of death in suspected FES.
The diagnosis of FES may be made at autopsy with the findings in the lungs and brain, plus a clinical scenario that supports such findings. In classic cases, the full-blown syndrome (with respiratory problems, neurological changes, anemia, thrombocytopenia, and rash) occurs before death. 6, 7 In other cases (when sudden cardiorespiratory collapse with immediate death occurs), the respiratory and neurological symptoms can be described, in retrospect, as accompanying the arrest. We propose that it should be acceptable to make a postmortem diagnosis of FES when there is sudden cardiorespiratory collapse occurring in the usual time frame that FES occurs, but before the full onset of clinical symptoms is recognized, so long as another more appropriate cause of death is not ascertained at autopsy. lower extremity and pelvis trauma. There was no loss of consciousness at the scene of the accident. The patient's radiological examination was significant for multiple fractures including the right third through ninth ribs anteriorly and laterally with no pneumothorax or contusions, a left L2 transverse process fracture, a complex fracture of the right iliac crest and superior acetabulum with central displacement of femoral head also involving the superior right pubic ramus and the left inferior pubic ramus, a comminuted fracture of distal left femur, a minimal fracture of the mid to distal diaphysis of right fibula, and a highly comminuted fracture of the os calcis with dislocation out from under the right subtalar joint. Computed tomography (CT) scans of the cervical spine and head were negative for acute traumatic injury.
On day 1, the patient had placement of a traction pin in the right femur and debridement and open reduction with internal fixation of his right foot fracture with repair of laceration. The patient's left femur was splinted. He also underwent embolization of the right superior gluteal artery and inferior vena cava filter placement. Never at any point did he experience respiratory failure or require intubation except for intubation associated with anesthesia for surgical procedures. Postoperatively, the patient, in his hospital room, remained awake and alert, although somewhat disoriented. Since admission, he had difficulties maintaining systolic blood pressure, which lingered in the 80s despite fluid resuscitation. He maintained oxygen saturations greater than 97% on 2 to 5 L of oxygen by nasal cannula.
On day 2 at 10:11 AM, physical examination was significant for diffuse rhonchi bilaterally, cool extremities with decreased pulses, abdominal tenderness, orthopedic injuries as mentioned, and incomprehensible speech. Laboratory findings were significant for a falling hemoglobin of 11.8 g/dL, down from 13.9 g/dL; a platelet count of 150,000 per KL; creatinine 2.1 mg/dL, up from 1.5 mg/dL; and potassium 5.8 mEq/L, up from 5.0 mEq/L. An echocardiogram showed a normal ejection fraction with no evidence of significant dysfunction. Chest x-ray findings were significant for patchy lung bases bilaterally. The patient then developed respiratory acidosis and mild metabolic acidosis. He was intubated at 12:15 PM and at 4:30 PM had a sudden cardiac event with some ventricular arrhythmia followed by cardiac arrest and asystole. Despite heroic measures, including cardiopulmonary resuscitation, multiple drugs, and cardioversion, the patient remained in asystole. After prolonged cardiac arrest and discussion with family, cardiopulmonary resuscitation was stopped. The only testing that was performed stat at the time of the cardiorespiratory event was a hemoglobin and hematocrit. They were 6.8 g/dL (having been 10.3, 11.8, and 13.9 g/dL at 5, 12, and 20 hours earlier, respectively) and 20% (having been 28.9%, 33.1%, and 39.6% at 5, 12, and 20 hours earlier, respectively). Because the death was related to trauma, the case was referred to the coroner. Autopsy revealed multiple blunt force injuries as previously described, hypertensive and atherosclerotic cardiovascular disease, and chronic obstructive pulmonary disease. There were multiple extensive areas of purple ecchymosis on the right side of the chest wall and right flank with extension onto anterior chest and abdomen. Multiple irregular abrasions and contusions were evident on the upper and lower extremities bilaterally. On internal examination, there were fractures of right ribs 1 to 9 and left ribs 3 to 6 and of the sternum. There were palpable fractures of the right foot and fibular region, the left femur, and right hip. Soft tissue hemorrhage was evident within the pelvis region. Sectioning of lungs disclosed a dark pink-red crepitant parenchyma. The pulmonary arteries and major bronchi were unremarkable, but there was evidence of emphysema grossly. The heart weighed 460 g. The intimal surface of the aorta and its major branches contained multiple areas of mild to severe, partially calcified atherosclerosis. The coronary arterial system was right predominant and contained multifocal areas of mild to focally severe atherosclerosis with severe lesions within the left anterior descending, as well as the distal right coronary arteries. The cardiac valves were unremarkable except for slight dystrophic calcification within the aortic valve. There was concentric left ventricular hypertrophy, measuring up to 1.7 cm. Brain sections revealed multiple petechiae-like hemorrhages within the white matter diffusely throughout the cerebrum (Figs. 1 and 2). There was no gross finding that accounted for the patient's precipitous drop in hemoglobin/hematocrit. Based on autopsy findings and the clinical history, the cause of death was determined to be FES due to multiple blunt force injuries with underlying hypertensive and atherosclerotic cardiovascular disease and chronic obstructive pulmonary disease.
DISCUSSION
Fat embolism syndrome is classically described as the onset of symptoms and signs of respiratory insufficiency, neurological deterioration, and petechial rash, typically within 12 to 72 hours following long-bone fracture or other major trauma. 2, 6 It is interesting to note that there are several reported causes of FES besides long-bone or pelvic fracture including soft tissue injury, liposuction, hepatic failure (fatty liver or necrosis), bone marrow harvest, bone marrow transplant, total parenteral nutrition, propofol infusion in intensive care, lymphography, burns, following extracorporeal circulation, acute sickle cell crisis, acute pancreatitis, and altitude sickness. 6 The majority of studies in the literature describe FES in the setting of long-bone or pelvic 
Pathogenesis
There has been debate over the theories of FES for over 100 years. There may be several factors at play leading to the full syndrome. 6 The pathogenesis of fat emboli syndrome is thought to involve mechanical obstruction and biochemical injury; however, these theories are controversial. These 2 theories originated in the 1920s with the work of Gauss and Lehman, respectively. 1 The mechanical theory states that the ruptured veins in fractured bones allow free fat into circulation. Particles greater than 8 Km in diameter can embolize. Microemboli of fat molecules aggregate in pulmonary microvasculature and sometimes migrate through the pulmonary capillary beds into systemic circulation (if smaller than 7Y10 Km) to cause damage to the cerebrum and other target organs such as the kidneys, skin, and retina via microvasculature occlusion. Systemic emboli can also occur due to a patent foramen ovale, seen in 20% to 34% of the normal population with a functional significance of 6%. 15Y17 Local ischemia and inflammation are propagated by free fatty acids released from neutral fat globules, aggregates of platelets and erythrocytes, and the recruitment of granulocytes. 5 The summation of effects damages the endothelium. The mechanical theory holds that the area of trauma is the site of origin of fat emboli.
The biochemical theory states that plasma mediators cause a systemic release of free fatty acids as chylomicrons, which coalesce to form fat globules large enough to occlude pulmonary capillaries. 1, 2 The free fatty acids damage pneumocytes, leading to acute respiratory distress syndrome (ARDS). 2 C-reactive protein has been hypothesized in nontraumatic FES as causing chylomicrons to combine, and the above physiological reaction ensues. 2, 18 The biochemical theory also suggests that the release of catecholamines after severe trauma mobilizes fatty acid stores of adipose tissue. 2 Other humoral factors such as serotonin, 5hydroxytryptamine, vasoactive amines, and histamine may further lung damage. 2 Kao et al 19 described FES-induced ARDS, mediated by nitric oxide, phospholipase A 2 , free radicals, and proinflammatory cytokines (tumor necrosis factor >, interleukin 1A, and interleukin 1). Pulmonary involvement is most common in FES, although it has been described without pulmonary involvement. 2 A delay from the traumatizing event and symptoms supports the biochemical theory of free fatty acid toxicity. 2 Aoki et al 20 support the theory that there are other factors besides mechanical obstruction by fat globules that must be necessary for the development of FES based on showing that not all patients with large fat emboli with a diagnosis of transesophageal echocardiogram develop FES.
Incidence
Fat embolism syndrome is the most common in the second to the third decades of life when long-bone fractures are most common. 2 Fat embolism syndrome is less common in children, perhaps because of differences in fat composition of pediatric bones. 2 Factors for worse prognosis are multiple fractures, development of coma, severe ARDS, pneumonia, and superimposed congestive heart failure. 2 The incidence of FES depends on the sensitivity and specificity of evaluation systems used by various investigators. Fat embolism occurs in more than 90% of patients with traumatic injury, whereas FES occurs in only 1% to 3.5% of patients with long-bone femur or tibia fractures. 1,2 A review by Bulger et al 9 reported FES incidence of 0.9% in patients with long-bone fractures based on Gurd's criteria. Ten Duis' 21 study of isolated femoral fractures had an incidence of 3.5%. Others show much higher incidences of FES: 8% to 22% in patients with femoral, tibial, and pelvic fractures. 1, 22 Chan et al 10 reported an 8.75% incidence of FES in fracture patients with 2 to 3 major clinical signs of FES, and 2.5% had the classic triad of respiratory distress, cerebral signs, and petechial hemorrhages. Gurd and Wilson 4 reported FES in 19% of major trauma cases. There are Some authors conclude that there is no association between fracture pattern or location and the incidence of FES, whereas others show increased incidence with increased number of fractures. 9, 21 Ten Duis' 21 study reported FES in 3% of patients with single femoral fractures, 10% of patients with 1 femoral and 1 tibial fracture, and 33% of patients with 2 fractured femurs. Similarly, Chan et al 10 reported that 35% of those suffering from multiple fractures had a diagnosis of FES. Other authors report incidences of 5% to 10% in patients with combination fractures of the lower limbs. 5 Fat embolism syndrome is more common in pelvic and lower limb fractures and rare in upper limb fractures. 21 Fat embolism syndrome is fatal in up to 10% of cases of the full-blown syndrome. 1, 22 Mortality of FES has improved in the last 2 decades. Mortality rates in the 1970s ranged from 10% to 20%, whereas more recent studies report mortality rates of 10% or less, likely because of better intensive care unit care and earlier diagnosis. 1 Postmortem evidence shows a much higher incidence of fat embolism, and often there is poor correlation with clinical findings. 6, 14 Evidence of fat embolism can be seen grossly or microscopically on autopsy even in cases where the diagnosis of FES could not be clinically established. 13 Hulman 18 demonstrated an autopsy incidence of fat emboli up to 80% in trauma patients, with clinical signs estimated at around 5% to 12% in the same patient population and 1% in patients with long-bone fractures. 12 Often, patients will not meet the classic clinical criteria, but will still be diagnosed with FES. 11 We concluded that our patient had FES and retrospectively attributed his clinical features (anemia, neurological deterioration, and respiratory insufficiency with eventual cardiopulmonary arrest) to FES.
Symptoms/Signs/Diagnostic Tools
There is a large array of clinical features reported to be manifestations of FES (see Table 1 for commonly reported clinical features). The most commonly reported symptoms of FES are respiratory (seen in 75% of patients), neurological (seen in up to 10%Y86% of patients), and a diffuse petechial rash in nondependent areas (seen in 20%Y60% of patients). 4Y6,11 Unexplained anemia is seen in 37% of cases, and thrombocytopenia is seen in 67% of cases. 6, 9 Several diagnostic tools have been used to detect fat emboli clinically, including identification of circulating fat globules in the blood, identification of urinary fat globules, bronchial alveolar lavage demonstrating fat globules, fat globules seen in pulmonary blood sample, transesophageal echocardiograms showing embolic showers, chest x-ray showing diffuse bilateral infiltrates, magnetic resonance imaging or CT showing evidence of cerebral FES, and high-definition CT showing pulmonary FES. 1, 5, 6 Clinical Diagnostic Criteria Several authors have proposed criteria to diagnose FES, most notably Gurd in the 1970s (see Table 2 for comparison of criteria). Gurd's criteria are often used today and define FES as 1 major criterion + 4 minor features + fat macroglobulinemia. 1, 7 The major features are petechial rash, respiratory symptoms, bilateral signs with positive radiographic changes, and cerebral signs unrelated to head injury. The minor criteria are tachycardia, pyrexia, retinal fat or petechiae, urinary fat globules or oliguria or anuria, sudden drop in hemoglobin level, sudden thrombocytopenia, high erythrocyte sedimentation rate (ESR), and fat globules in sputum. Other criteria have also been proposed, including adaptations of Gurd's criteria and those of Lindeque based on respiratory features. 1, 6 Schonfeld's scoring system is commonly used as mentioned by Talbot and Schemitsch. 1 Weisz et al 23 confirmed the diagnosis of FES in children. Their classification of signs was a modification of Gurd's criteria. Weisz et al 23 do not specifically use the term fat embolism syndrome but imply it was based on the fact that they compare their criteria for fat emboli with those of Gurd. 23 Symptomatic children had 5 to 10 signs, whereas asymptomatic children had less than 3 minor signs. Fat embolism was confirmed histologically in symptomatic patients. Fat embolism was confirmed as the cause of death based on any of the following major signs: retinal embolism, positive skin/lung/kidney biopsy, or histological findings at autopsy. 23 Weisz et al accepted that there are often contributing medical conditions leading to death: shock and bacteremia are aggravating factors in fat embolism and together cause fatality. 23 Vedrinne et al 24 call to mind that the diagnosis of FES is difficult to make in a trauma patient because of associated injuries. Trauma patients often have multiple injuries and complications: chest trauma, pulmonary contusion, aspiration pneumonia, massive transfusions causing hypoxia and pulmonary infiltrates, cerebral dysfunction masked by sedation, petechial rash, low platelets after blood transfusions, and so on. Vedrinne et al 24 suggest that previous criteria are not useful in patients with a combination of injuries and proposed a different scoring system for a polytrauma patient based on degrees of findings. Fat embolism syndrome was highly suspected in patients with a score greater than or equal to 8. Table 2 shows a comparison of several of the proposed criteria for FES.
Chan et al 10 The varying criteria for FES make both the clinical diagnosis and the postmortem diagnosis difficult to ascertain. There is no criterion standard for clinical diagnosis, so it is almost impossible to evaluate the value of these criteria systems, especially because diagnosis can be so difficult to make clinically. Lack of universal criteria for diagnosis and limited studies, especially of autopsy findings, can make the diagnosis of FES particularly difficult for forensic pathologists. Fat emboli in pulmonary vasculature can be seen in almost all trauma patients at autopsy, but not all the patients die of FES. 24 There is often poor agreement between postmortem and clinical findings, which further complicates the issue. 14 Fat embolism syndrome cannot always be accurately diagnosed clinically because often symptoms can be masked, can be unrecognized, or develop so rapidly that they are not recognized, especially in cases like ours with a fulminant clinical course and rapid death. Other studies have also failed to diagnose the major clinical features set by Gurd and show that often the minor criteria are nonspecific for accurate diagnosis. 24, 25 There are even reports of FES lacking the most common clinical featurerespiratory involvement. 5 In 1 case report of rapid development of FES, transesophageal echocardiogram aided in the diagnosis of fat emboli in circulation; however, final diagnosis was not made until autopsy revealed fat emboli in the heart, lungs, and kidney. 3 
Autopsy Diagnosis of Fat Embolism and FES
Pathologists can make definitive diagnosis of fat emboli by histopathologic examination. Tissue samples with suspected fat emboli can be embedded in paraffin, sectioned, and stained with hematoxylin-eosin (H&E). 19 Hematoxylin-eosin staining of the lungs may show alveolar edema and hemorrhage with fat droplet depositions (cleared-out circular and oval spaces). 19 These cleared-out areas represent areas where fat droplets existed before being leached out of the tissue block during processing. Fat can be specifically stained in frozen tissue with oil red O showing fat droplets as red, as used in our case, Sudan black showing fat droplets as brown to black, and Sudan III showing fat droplets as orange. 19 Osmic acid can also be used to study fat embolism but has several disadvantages. 26 It is expensive and toxic and does not fix tissue as well. 26 Tracy and Walia 26 proposed a new method of fixing lipids for later staining that is preferred over frozen section and osmic acid. This method involves immersing formalin-fixed tissues in linoleic acid with ethylene glycol and exposing the sample to chromic acid. The fixed lipid can then be stained by fat-soluble stains such as oil red O. 26 We suggest a tiered approach for diagnosis of fatal FES (see below) by correlating clinical symptoms with autopsy findings. A similar approach was used by Saldeen 27 in dividing his study population into 3 groups. In his study, pathologicoanatomic signs of fat embolism were seen in 24% of patients, and in 11% of cases, no other changes could explain death besides fat embolism. 27 The group with a diagnosis of fat embolism at autopsy had no other changes observed that could explain death and had clinical symptoms of FES. According to Saldeen, 27 patients were divided into 3 groups. Group 1 included patients who at autopsy were given a diagnosis of fat embolism, and no other change observed could explain their death. Group 2 included patients who at autopsy were given a diagnosis of fat embolism, but other changes present possibly could explain their death. Group 3 included patients who at autopsy were not given a diagnosis of fat embolism, but many had small amounts of fat in pulmonary vessels. Saldeen 27 noted that clinical symptoms of fat embolism were more frequent in group 1; however, only 4 patients had a clinical diagnosis of fat embolism before autopsy. Autopsy findings suggesting fat embolism included fibrin in pulmonary vessels; congealed fat in venous circulation from site of injury to heart and branches of pulmonary artery; fat seen microscopically in capillaries of lungs, kidney, and brain; and pulmonary hemorrhages around fat-filled vessels. 27 Saldeen 27 does not, however, provide criteria of ''pathologicoanatomic signs,'' nor does the Article provide criteria for ''clinical symptoms.'' Emson 17 grouped 100 trauma deaths according to autopsy findings. Group 1 had systemic fat emboli that did not contribute to symptoms or death. Group 2 had systemic fat emboli that had doubtful significance in relation to symptoms and death. Group 3 had systemic fat emboli that gave rise to symptoms and death. This latter group was subdivided into those in whom systemic fat emboli were a contributing cause of death and those in whom it was a main cause of death. 17 Emson 17 provides a grading system for severity of fat emboli (Table 3) .
Determining the significance of fat emboli found at autopsy as a cause of death remains controversial. 14 For the forensic pathologist, it is important to document signs of fat emboli for the determination of cause of death. 28 How should one determine the severity of pulmonary fat emboli to determine the role fat emboli played in a patient's death? Several grading systems have been developed, suggesting that the severity of clinical manifestations directly correlates with the postmortem measurement of fat emboli. 14 Table 3 shows a comparison of several grading systems. Emson 17 counted fat emboli at least 10 Km in diameter in frozen lung sections that were stained with oil red O. 17 He made no attempt to count cerebral emboli, stating that any cerebral fat emboli were grave significance compared with pulmonary emboli. 17 He concluded that pulmonary fat emboli increased with degree of trauma and that systemic fat emboli were common in patients with severe pulmonary fat embolism. 17 Bunai et al 29 argued that grading systems for the severity of fat emboli are not objective so there will be difficulty in determining how big a role fat emboli played in cause of death. They supported the use of quantitative image analysis of the size and location of fat emboli to make an objective and reproducible grading system. 29 Turillazzi et al 14 proposed that postmortem diagnosis of FES based on histology of fat globules needs quantitative analysis of the size and location of pulmonary fat emboli. They used quantitative morphometry and confocal microscopy to analyze histological sections of lungs of FES cases. They suggested that the most reliable parameter that correlated histological evidence of FES with clinical data was the total percentage of embolized tissue area compared with total tissue area of all samples. Their proposed grading system is based on the percentage of embolized tissue areas found. Although this might prove to be more accurate, it would seem to be slightly too week of skeletal or severe soft tissue trauma, and autopsy identification of moderate to extensive amounts of pulmonary intravascular fat emboli, with or without brain and/or other organ fat emboli, and without another satisfactory explanation for death. In these cases, the sudden cardiorespiratory collapse might theoretically be considered an extreme manifestation of respiratory distress, thus fulfilling one of the clinical criteria of the FES. Also of note is the suggestion that certain persons, especially those with underlying severe natural disease or other serious injuries, may be particularly susceptible to sudden cardiorespiratory collapse due to fat embolism. In such cases, it is appropriate to include both the underlying disease or injuries and FES as contributory factors in death.
In cases where there are sufficient injuries, natural disease processes, or a combination of injuries and disease to explain death, with a sufficient survival time to allow for fat embolism to occur, and autopsy discloses moderate to extensive fat emboli, it is reasonable to conclude that FES may have played a contributory role in death.
Furthermore, we suggest that in cases of sudden death occurring in trauma patients as described above, where there is only a mild amount of fat emboli identified within the lungs, but with no other explanation for death, pathologists should also consider the possibility of FES. In such cases, the term possible or probable may be used in combination with fat embolism syndrome.
Finally, if there are no clinical features of FES, or there is no sudden cardiorespiratory collapse in patients who have experienced skeletal or severe soft tissue trauma, but other injuries and/ or natural disease manifestations are sufficient to explain death, and only scattered, minimal amounts of fat emboli are evident within the pulmonary microvasculature at autopsy, then it is reasonable to conclude that the fat emboli are incidental findings.
To better elucidate the existence of fat emboli at autopsy, we suggest that forensic pathologists do the following at autopsy when FES is suspected: & Perform chart review for clinical signs and symptoms that would support the diagnosis of FES. & Consider obtaining blood and urine samples from hospital lab for further testing (or ask laboratory to perform additional tests on antemortem samples). & Look for and document gross evidence of fat emboli (fat droplets visualized in pulmonary vessels; white matter petechial hemorrhages in brain). & Freeze lung and other tissue samples for definitive fat staining (versus utilization of other staining techniques as described above). & Attempt to identify fat emboli microscopically, particularly within lungs and brain. & Grade pulmonary fat emboli using one of the above mentioned grading systems. & Consider evaluating urine for fat globules. & Consider collecting blood/clots from autopsy and evaluating (via frozen section) for fat globules. & Consider removing eyes for retinal examination.
CONCLUSIONS
The FES is a well-known clinicopathologic entity that typically occurs in patients who have sustained severe lower extremity and/or pelvic skeletal trauma. Classically, it is characterized by the onset of respiratory, neurological, and cutaneous symptoms, typically occurring within several hours to days of trauma, and the syndrome is frequently lethal. The pathologic findings of FES include the identification of numerous fat emboli within the microvasculature of the lungs. Strictly speaking, FES is a clinical diagnosis. In this article, a review of FES reveals that, even from a clinical standpoint, opinions vary as to the diagnostic criteria. As a result of the variant clinical criteria used for diagnosis, in combination with the fact that in certain cases where death occurs, clinical criteria may not have yet developed or been recognized, we propose a set of criteria for establishing a postmortem diagnosis of FES. By implementing these criteria, forensic pathologists should be better equipped to render a diagnosis of FES at autopsy.
